SCHEMBL28956672

SCHEMBL28956672

NCc1ccc(-c2cnn(CC3CC3)c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 1/20 0.53
▸ PIK3CA P42336 1/20 0.53
▸ PIK3CB P42338 1/20 0.53
▸ PI4KA P42356 1/20 0.53
▸ PIK3CG P48736 1/20 0.53
▸ PI4KB Q9UBF8 1/20 0.53
▸ CREBBP Q92793 2/20 0.43
▸ HRH3 Q9Y5N1 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ KCNH2 Q12809 1/20 0.40
▸ CYP2A6 P11509 1/20 0.38
▸ TAAR1 Q96RJ0 1/20 0.38
▸ MTOR P42345 1/20 0.37
▸ KDM5B Q9UGL1 1/20 0.37
▸ KDM1A O60341 1/20 0.37
▸ TTK P33981 1/20 0.36
▸ FGFR1 P11362 1/20 0.36
▸ FGFR2 P21802 1/20 0.36
▸ FGFR3 P22607 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15721483 0.80 GABRA1 (0.46) PIK3CDPIK3CAPIK3CBPI4KAPIK3CG
Ammonia Solution, Strong SCHEMBL28956673 0.80 PIK3CD (0.51) PIK3CDPIK3CAPIK3CBPI4KAPIK3CG
SCHEMBL18986003 0.78 PIK3CD (0.62) PIK3CDPIK3CAPIK3CBPI4KAPIK3CG
SCHEMBL17091242 0.78 PRMT5 (0.51) PIK3CDPIK3CAPIK3CBPI4KAPIK3CG
SCHEMBL22919044 0.75 USP30 (0.46) —
SCHEMBL28956713 0.75 PIK3CD (0.49) PIK3CDPIK3CAPIK3CBPI4KAPIK3CG
SCHEMBL22918695 0.75 PRMT5 (0.53) HRH3L3MBTL1KCNH2CYP2A6TAAR1
SCHEMBL15729226 0.74 LOXL2 (0.52) PIK3CDPIK3CAPIK3CBPI4KAPIK3CG
SCHEMBL22918721 0.74 HRH3 (0.45) HRH3L3MBTL1KCNH2PIM1PIM3
SCHEMBL19668149 0.74 PIK3CD (0.51) PIK3CDPIK3CAPIK3CBPI4KAPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260109697-A1 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2026-04-23 — — US disclosed
US-20220267320-A1 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2022-08-25 — — US disclosed
EP-4003992-A1 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL) -PYRIMIDINE DERIVATIVES Merck Patent GmbH (DE) 2022-06-01 — — EP disclosed
CN-114174293-A 4- (imidazo [1,2-a ] pyridin-3-yl) -pyrimidine derivatives 默克专利股份公司 2022-03-11 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260109697-A1 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES CHUK, CNKSR1, KIT PIK3CD 812/4885PIK3CA 248/4885PIK3CB 739/4885
US-20220267320-A1 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES NCOA3, NCOR1, NCOA4 PIK3CD 1471/4885PIK3CA 563/4885PIK3CB 1139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback